BioNano Genomics Inc vs DoorDash Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.31M), while DoorDash Inc trades at $210 (market cap $90.93B). The key difference: DoorDash Inc is far larger — about 6831.7× BioNano Genomics Inc's market cap, and DoorDash Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | DASH | |
|---|---|---|
Market Cap | $13.31M | $90.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $281.74 |
52-Week Low | $1.06 | $146.60 |
Enterprise Value | $15.92M | $88.89B |
Trailing returns across standard periods
Latest headlines on both assets
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →